Abstract:Integrin β4 (ITGB4) is a member of the integrin family, which plays a crucial role in mediating cell adhesion to the extracellular matrix. Recent studies have demonstrated that ITGB4 is involved in tumorigenesis and metastasis during the development of cancer. However, the role of ITGB4 in oral squamous cell carcinoma (OSCC) remains unclear. A Multiplex immunohistochemistry (OPALTM, mIHC) assay was employed to stain ITGB4, ALDH1, PD-L1, cytokeratin (CK), CD8 and PD-1 in a human OSCC tissue microarray, containing 26 normal oral epithelium samples, 21 oral epithelium dysplasia samples and 76 OSCC samples. The expression pattern and clinicopathological characteristics of ITGB4 were analyzed and compared with those of PD-1, PD-L1, ALDH1 and CD8. The correlation between subgroups of tumor cells, including ITGB4+PD-L1+ and ITGB4+ALDH1+, and subgroups of T cells, including CD8+ and CD8+PD-1+, was evaluated using two-tailed Pearson's statistics. A Kaplan–Meier curve was built, and a log-rank test was performed to analyze the survival rate of different subgroups. The mIHC staining results show that ITGB4 was mostly expressed in the tumor cells, with a significant increase in the OSCC specimens compared with normal oral epithelium and oral epithelium dysplasia. The paired analysis, conducted between the OSCC tumor tissue and normal paracancer mucosa, confirmed the results. The study further revealed that ITGB4+PD-L1+ cancer cells, but not ITGB4+ALDH1+ cancer cells, were significantly associated with the infiltration of CD8+ T cells (positivity p = 0.005, positive number p = 0.03). Additionally, ITGB4+PD-L1+ tumor cells were positively correlated with CD8+PD-1+ T cells (positivity p = 0.02, positive number p = 0.03). Most intriguingly, the subgroup of ITGB4/PD-L1high with CD8/PD-1high displayed the best prognosis compared with the other considered subgroups. The results show that the expression of ITGB4 was increased in OSCC compared with normal oral mucosa. Furthermore, a specific subgroup with high levels of expression of ITGB4/PD-L1 and CD8/PD-1 was found to have a relatively better prognosis compared with the other subgroups. Ultimately, this study sheds light on the potential role of ITGB4 in OSCC and provides a basis for further investigation.

The Expression of Thymidine Phosphorylase in Oral Squamous Cell Carcinoma and Its Relationship with Microvessel Density and Prognosis

Expressions and Significances of Topoisomeraseⅱ and Multidrug Resistance-Associated Protein in Human Esophageal Squamous Cell Carcinoma

A study on thymidine phosphorylase in endometrial carcinoma

[Relationships among the Expression of Thymidylate Synthase, Thymidine Phosphorylase, and Dihydropyrimidine Dehydrogenase and the Prognosis of Breast Cancer].

Thymidine Phosphorylase Expression and Microvascular Density Correlation Analysis in Canine Mammary Tumor: Possible Prognostic Factor in Breast Cancer

[Expression of Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-3 and Nm23-H1 in Oral Squamous Cell Carcinoma].

Prognostic Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Carcinoma of Ampulla of Vater.

Expression of Thymidine Phosphorylase and Its Relation to Angiogenesis in Non-Small Cell Lung Cancer

[Relationship of Expression of Inducible Nitric Oxide Synthase to Microvessel Density in Oral Squamous Cell Carcinomas]

Clinicopathologic and Prognostic Significance of Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase Activity in Human Colorectal Carcinoma

Thymidylate synthase expression in epithelial ovarian cancer: relationship with thymidine phosphorylase expression and prognosis

Implications of TP-positive CAFs in the Bone Invasion of Oral Squamous Cell Carcinoma

Clinical Significance of Detection of Serum VEGF and TP Levels in the Patients with Gastrointestinal Tumors

Express of Mir-17-5p in Oral Squamous Cell Carcinoma and Its Clinical Significance

Thymidine Phosphorylase and Angiogenesis in Breast Carcinoma

Mrna Expression of TPX2 and Its Reference with Clinical Pathology in Esophageal Cancer

Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1high with CD8/PD-1high

Peripheral Blood Dendritic Cells and Vascular Endothelial Growth Factor in Oral Squamous Cell Carcinoma: Correlation Analysis and in Vitro Study

Expression of PTEN in preoperative chemotherapy with lobaplatin in oral squamous cell carcinoma

Evaluation of VEGF, BDNF, TRKB expression in oral epithelial dysplasia, oral verrucous carcinoma and oral squamous cell carcinoma and their role as prognostic indicator

Nuclear Expression of metastasis-associated Protein 1 (MTA1) is Inversely Related to Progression of Oral Squamous Cell Carcinoma in Taiwan